SinoMab BioScience Limited — Capital/Financing Update 2019

Oct 30, 2019

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

This Application Form uses the same terms as defined in the prospectus of SinoMab BioScience Limited (the “ Company ”) dated October 31, 2019 (the “ Prospectus ”).

本申請表格使用中國抗體製藥有限公司（「 本公司 」）於二零一九年十月三十一日刊發的招股章程（「 招股章程 」）所 Staple your 界定的詞語。 payment here Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered 請將股款 or sold in the United States without registration or an exemption from registration under the U.S. Securities Act. 本申請表格及招股章程概不構成在香港以外司法權區要約出售或游說要約購買香港發售股份。若無根據美國證 緊釘在此 券法登記或豁免登記，香港發售股份不得在美國提呈發售或出售。 This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction. 在任何根據當地法例不得發送、派發或複製本申請表格及招股章程的司法權區內概不得發送或派發或複製（不 論方式，也不論全部或部分）本申請表格及招股章程。 Copies of the Prospectus, all related Application Forms and the other documents specified in the “Documents Delivered to the Registrar of Companies and Available for Inspection” in Appendix V to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by Section 38D of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”), Hong Kong Securities Clearing Company Limited (“ HKSCC ”), the Securities and Futures Commission of Hong Kong (the “ SFC ”) and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents. 招股章程、所有相關申請表格及招股章程附錄五「送呈公司註冊處處長及備查文件」一節所述其他文件已遵照香 港法例第 32 章公司（清盤及雜項條文）條例第 38D 條的規定，送呈香港公司註冊處處長登記。香港交易及結算所 有限公司、香港聯合交易所有限公司（「 聯交所 」）、香港中央結算有限公司（「 香港結算 」）、香港證券及期貨事務 監察委員會（「 證監會 」）及香港公司註冊處處長對此等文件的內容概不負責。 SinoMab BioScience Limited 中國抗體製藥有限公司 (Incorporated in Hong Kong with limited liability) （於香港註冊成立的有限公司） Stock Code : 3681 股份代號 : 3681 Offer Price : Not more than HK$9.60 per Offer Share and expected to be not less than HK$7.60 per Offer Share, plus brokerage of 1%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong Dollars and subject to refund) 發售價 : 不超過每股發售股份 9.60 港元且預期不少於每股發售股 份 7.60 港元，另加 1% 經紀佣金、0.0027% 證監會交 易徵費及 0.005% 聯交所交易費（須於申請時以港元繳 足，多繳股款可予退還） You should read this Application Form in conjunction with the Prospectus, which contains further information on the application procedures. ， 一 。 招股章程尚有關於申請程序的其他資料 本申請表格應與招股章程 併閱讀 Application Form 申請表格 To: SinoMab BioScience Limited 致：中國抗體製藥有限公司 Joint Sponsors 聯席保薦人 Joint Global Coordinators 聯席全球協調人 Joint Bookrunners 聯席賬簿管理人 Joint Lead Managers 聯席牽頭經辦人 Hong Kong Underwriters 香港包銷商

申請人聲明

Applicants’ declaration

本人╱吾等同意本申請表格及招股章程的條款及條件 以及申請程序。見本申請表格「填交本申請表格的效 用」一節。

I/We agree to the terms and conditions and application procedures in this Application Form and the Prospectus. Please refer to the “Effect of completing and submitting this Application Form” section of this Application Form.

警告：任何人士只限作出一次為其利益而進行的認購 申請。請參閱本申請表格「填交本申請表格的效用」一 節最後四點。

Warning: Only one application may be made for the benefit of any person. Please refer to the last four bullets of the “Effect of completing and submitting this Application Form” section of this Application Form.

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

Signed by (all) applicant(s) (all joint applicants must sign): 由（所有）申請人簽署（所有聯名申請人必須簽署）：

Signed by (all) applicant(s) (all joint applicants must sign): For Broker use 此欄供經紀填寫 Lodged by 遞交申請的經紀 由（所有）申請人簽署（所有聯名申請人必須簽署）： Broker No. 經紀號碼 Broker’s Chop 經紀印章 Date: 日期 : ╱ ╱ D 日 M 月 Y 年 Number of Hong Kong Offer Shares applied for (not more than 9,106,500 Shares) Cheque/banker’s cashier order number 支票╱銀行本票號碼 申請香港發售股份數目（不超過 9,106,500 股） Name of bank on which cheque/banker’s cashier order is drawn (see “How to make your application” section) 兌現支票╱銀 Total amount 總額 行本票的銀行名稱（見「申請手續」一節） HK$ 港元 Name in English (in BLOCK letters) 英文姓名╱名稱（ 正楷 ） Family name or company name 姓氏或公司名稱 Forename(s) 名字 Name in Chinese 中文姓名╱名稱 Family name or company name 姓氏或公司名稱 Forename(s) 名字 Occupation in English 職業（以英文填寫） Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No.[#] (Please delete as appropriate) 香港身份證號碼╱ 護照號碼╱香港商業登記號碼（請刪除不適用者）[#] Names of all other joint applicants in English (if any, in BLOCK letters) Hong Kong Identity Card No./Passport No./Hong Kong Business 所有其他聯名申請人的英文姓名╱名稱（如有， 正楷 ） Registration No. of all other joint applicants[#] (Please delete as appropriate) 所有其他聯名申請人的香港身份證號碼╱護照號 1) 碼╱香港商業登記號碼（請刪除不適用者）[#] 1) 2) 2) 3) 3) Hong Kong address in English and telephone no. (joint applicants should give the address and the telephone number of first-named applicant only in BLOCK letters) 香港地址（以英文 正楷 填寫）及電話號碼（聯名申請人只須填寫排名首位申請人的地址及電話號碼） Telephone No. 電話號碼 For Nominees: You will be treated as applying for your own benefit if you do not complete this section. Please provide an account number or identification code for each (joint) beneficial owner. 由代名人遞交：代名人若不填寫本節，是項認購申請 將視作為 閣下利益提出。請填寫每名（聯名）實益擁有人的 賬戶號碼或識別編碼。

ADDRESS LABEL 地址標貼 (Your name(s) and address in Hong Kong in BLOCK letters 請用英文 正楷 填寫 姓名 ╱ 名稱 及 香港 地址 ）

For internal use 此欄供內部使用

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

• (1) An individual must provide his Hong Kong Identity Card number or, if he does not hold a Hong Kong Identity Card, his passport number. A body corporate must provide its Hong Kong Business Registration number. Each joint applicant must provide its or his relevant number. The Hong Kong Identity Card number(s)/passport number(s)/Hong Kong Business Registration number(s) will be transferred to a third party for checking the Application Form’s validity.

個別人士須填寫其香港身份證號碼或（如非香港身份證持有人）護照號碼。法人團體須填寫其香 港商業登記號碼。每名聯名申請人均須提供其相關號碼。該等香港身份證號碼╱護照號碼╱香 港商業登記號碼將轉交第三方以核實申請表格的有效性。 (2) Part of the Hong Kong Identity Card number/passport number of you or, for joint applicants, the first-named applicant may be printed on your refund cheque (if any). Your banker may require verification of your Hong Kong Identity Card number/passport number before you can cash your refund cheque. 日後如需退回申請股款，退款支票上或會印有 閣下或（如屬聯名申請人）排名首位申請人的香 港身份證號碼╱護照號碼的一部分。銀行兌現退款支票前或會要求查證 閣下的香港身份證號 碼╱護照號碼。 (3) If an application is made by an unlisted company and: ‧ the principal business of that company is dealing in securities; and ‧ you exercise statutory control over that company, then the application will be treated as being made for your benefit. 倘若申請人是一家非上市公司，而： ‧ 該公司主要從事證券買賣業務；及 ‧ 閣下對該公司可行使法定控制權， 是項申請將視作為 閣下的利益提出。

This page is intentionally left blank 此乃白頁 特意留空

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

How to make your application

1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 300 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.

1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 300 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.	1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 300 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.	1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 300 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.	1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 300 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.
SinoMab BioScience Limited (Stock Code 3681) (HK$9.60 per Hong Kong Offer Share) NUMBER OF HONG KONG OFFER SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
No. of Hong Kong Offer Shares applied for Amount payable on application HK$	No. of Hong Kong Offer Shares applied for Amount payable on application HK$	No. of Hong Kong Offer Shares applied for Amount payable on application HK$	No. of Hong Kong Offer Shares applied for Amount payable on application HK$
300 600 900 1,200 1,500 1,800 2,100 2,400 2,700 3,000 4,500 2,909.02 5,818.05 8,727.06 11,636.09 14,545.11 17,454.13 20,363.15 23,272.17 26,181.20 29,090.22 43,635.33	6,000 7,500 9,000 10,500 12,000 13,500 15,000 30,000 45,000 60,000 75,000 58,180.44 72,725.54 87,270.65 101,815.76 116,360.87 130,905.98 145,451.09 290,902.18 436,353.26 581,804.35 727,255.44	90,000 105,000 120,000 135,000 150,000 300,000 450,000 600,000 750,000 900,000 1,050,000 872,706.53 1,018,157.62 1,163,608.70 1,309,059.79 1,454,510.88 2,909,021.76 4,363,532.64 5,818,043.52 7,272,554.40 8,727,065.28 10,181,576.16 樣	1,200,000 1,350,000 1,500,000 3,000,000 4,500,000 6,000,000 7,500,000 9,000,000 9,106,500(1) 11,636,087.04 13,090,597.92 14,545,108.80 29,090,217.60 43,635,326.40 58,180,435.20 72,725,544.00 87,270,652.80 88,303,355.52 (1)Maximum number of Hong Kong Offer Shares you may apply for.
2. Complete the form in English in BLOCK letters and sign it. Only written signatures will be accepted (and not by way of personal chop). 3. Staple your cheque or banker’s cashier order to the form. Each application for the Hong Kong Offer Shares must be accompanied by either one separate cheque or one separate banker’s cashier order. Your application will be rejected if your cheque or banker’s cashier order does not meet all the following requirements: ple
The cheque must:		Banker’s cashier order must:
‧be in Hong Kong dollars; ‧not be post-dated; ‧be made payable to “CMB Wing Lung (Nominees) Limited–SinoMab Public Offer”; ‧be crossed “Account Payee Only”; a
‧be drawn on your Hong Kong dollar bank account in Hong Kong; and ‧show your account name, which must either be pre-printed on the cheque, or be endorsed on the back by a person authorised by the bank. This account name must correspond with your name. If it is a joint application, the account name must be the same as the first-named applicant’s name. S		‧be issued by a licensed bank in Hong Kong, and have your name certified on the back by a person authorised by the bank. The name on the banker’s cashier order must correspond with your name. If it is a joint application, the name on the back of the banker’s cashier order must be the same as the first-named applicant’s name.

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

1. Tear off the Application Form, fold it once and lodge your completed Application Form (with cheque or banker’s cashier order attached) to one of the collection boxes at any of the following branches of:

CMB Wing Lung Bank Limited Branch Name Address Hong Kong Island Head Office 45 Des Voeux Road Central Aberdeen Branch 201 Aberdeen Main Road Kowloon Tsim Sha Tsui Branch 4 Carnavon Road Mongkok Branch B/F, CMB Wing Lung Bank Centre, 636 Nathan Road New Territories Tsuen Wan Branch 251 Sha Tsui Road 5. Your Application Form can be lodged at these times: — Thursday, October 31, 2019 9:00 a.m. to 5:00 p.m. — Friday, November 1, 2019 9:00 a.m. to 5:00 p.m. — Saturday, November 2, 2019 9:00 a.m. to 1:00 p.m. — Monday, November 4, 2019 9:00 a.m. to 5:00 p.m. Tuesday, November 5, 2019 — 9:00 a.m. to 12:00 noon 6. The latest time for lodging your application is 12:00 noon on Tuesday, November 5, 2019. The application lists will be opened between 11:45 a.m. to 12:00 noon on that day, subject only to the weather conditions, as described in the section headed “How to Apply for Hong Kong Offer Shares – 10. Effect of Bad Weather on the Opening of the Application Lists” in the Prospectus. The applications for the Hong Kong Offer Shares will commence at 9:00 a.m. on Thursday, October 31, 2019 through 12:00 noon Tuesday, November 5, 2019. The application monies (including the brokerage fees, SFC transaction levies and Stock Exchange trading fees) will be held by the receiving bank and on behalf of the Company after the closing of the application lists and the refund monies, if any, will be returned to the applicants without interest on or before Monday, November 11, 2019. Investors should be aware that the dealings in the Shares on the Stock Exchange are expected to commence on Tuesday, November 12, 2019.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

申請手續

1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為 300 股香港發售股份，並為下 表所列的其中一個數目，否則恕不受理。

中國抗體製藥有限公司（股份代號3681） （每股香港發售股份9.60港元） 可供申請認購股份數目及應繳款項	中國抗體製藥有限公司（股份代號3681） （每股香港發售股份9.60港元） 可供申請認購股份數目及應繳款項	中國抗體製藥有限公司（股份代號3681） （每股香港發售股份9.60港元） 可供申請認購股份數目及應繳款項	中國抗體製藥有限公司（股份代號3681） （每股香港發售股份9.60港元） 可供申請認購股份數目及應繳款項
申請認購的 申請時 香港發售 應繳款項 股份數目 （港元）	申請認購的 申請時 香港發售 應繳款項 股份數目 （港元）	申請認購的 申請時 香港發售 應繳款項 股份數目 （港元）	申請認購的 申請時 香港發售 應繳款項 股份數目 （港元）
300 600 900 1,200 1,500 1,800 2,100 2,400 2,700 3,000 4,500 2,909.02 5,818.05 8,727.06 11,636.09 14,545.11 17,454.13 20,363.15 23,272.17 26,181.20 29,090.22 43,635.33	6,000 7,500 9,000 10,500 12,000 13,500 15,000 30,000 45,000 60,000 75,000 58,180.44 72,725.54 87,270.65 101,815.76 116,360.87 130,905.98 145,451.09 290,902.18 436,353.26 581,804.35 727,255.44	90,000 105,000 120,000 135,000 150,000 300,000 450,000 600,000 750,000 900,000 1,050,000 872,706.53 1,018,157.62 1,163,608.70 1,309,059.79 1,454,510.88 2,909,021.76 4,363,532.64 5,818,043.52 7,272,554.40 8,727,065.28 10,181,576.16 樣	1,200,000 1,350,000 1,500,000 3,000,000 4,500,000 6,000,000 7,500,000 9,000,000 9,106,500(1) 11,636,087.04 13,090,597.92 14,545,108.80 29,090,217.60 43,635,326.40 58,180,435.20 72,725,544.00 87,270,652.80 88,303,355.52 (1) 閣下可申請認購的香港發售股 份最高數目。
2. 以英文正楷填妥及簽署申請表格。只接納親筆簽名（不得以個人印章代替）。 3. 閣下須將支票或銀行本票釘於表格上。每份香港發售股份申請須附一張獨立開出支票或一張獨 立開出銀行本票。支票或銀行本票必須符合以下所有規定，否則有關的認購申請不獲接納： mple
支票必須：		銀行本票必須：
‧ 為港元； ‧ 不得為期票； ‧ 註明抬頭人為「招商永隆受託代管有限公司－中國抗體製藥公開發售」； ‧ 劃線註明「只准入抬頭人賬戶」； Sa
‧ 從 閣下在香港的港元銀行賬戶中開出；及 ‧ 顯示 閣下的賬戶名稱，而該賬戶名稱必須 已預印在支票上，或由有關銀行授權的人士 在支票背書。賬戶名稱必須與 閣下姓名╱ 名稱相同。如屬聯名申請，賬戶名稱必須與 排名首位申請人的姓名╱名稱相同。		‧ 須由香港持牌銀行開出，並由有關銀行授權 的人士在銀行本票背面簽署核證 閣下姓名 ╱名稱。銀行本票所示姓名╱名稱須與 閣 下姓名╱名稱相同。如屬聯名申請，銀行本 票背面所示姓名╱名稱必須與排名首位申請 人的姓名╱名稱相同。

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

1. 請撕下申請表格，對摺一次，然後將填妥的申請表格（連同支票或銀行本票）投入下列任何一家 分行的收集箱：

招商永隆銀行有限公司 分行名稱 地址 港島區 總行 德輔道中 45 號 香港仔分行 香港仔大道 201 號 九龍區 尖沙咀分行 加拿分道 4 號 旺角分行 彌敦道 636 號招商永隆銀行中心地庫 新界區 荃灣分行 沙咀道 251 號 5. 閣下可於下列時間遞交申請表格： 二零一九年十月三十一日（星期四）－上午九時正至下午五時正 二零一九年十一月一日（星期五）－上午九時正至下午五時正 二零一九年十一月二日（星期六）－上午九時正至下午一時正 二零一九年十一月四日（星期一）－上午九時正至下午五時正 二零一九年十一月五日（星期二）－上午九時正至中午十二時正 6. 截止遞交申請的時間為二零一九年十一月五日（星期二）中午十二時正。本公司將於當日上午 十一時四十五分至中午十二時正期間登記認購申請，惟僅受招股章程「如何申請香港發售股份－ 10. 惡劣天氣對開始辦理申請登記的影響」一節所述的天氣情況所限。 香港發售股份申請將會自二零一九年十月三十一日（星期四）上午九時正起直至二零一九年十一 月五日（星期二）中午十二時正止。申請款項（包括經紀佣金、證監會交易徵費及聯交所交易費） 將由收款銀行於截止辦理申請登記後代表本公司持有，且退款金額（如有）將於二零一九年十一 月十一日（星期一）或之前不計利息退還予申請人。投資者務請注意，預期股份將於二零一九年 十一月十二日（星期二）於聯交所開始買賣。

1. 閣下可於下列時間遞交申請表格：

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

==> picture [29 x 43] intentionally omitted <==

==> picture [29 x 43] intentionally omitted <==

SinoMab BioScience Limited 中國抗體製藥有限公司

(Incorporated in Hong Kong with limited liability)

• GLOBAL OFFERING

• Conditions of your application ‧ agree that none of the Company, the Joint Sponsors, the Joint A. Who can apply Global Coordinators, the Joint Bookrunners, the Joint Lead Managers, the Underwriters, their respective directors, officers,

• 1. You and any person(s) for whose benefit you are applying must employees, partners, agents, advisors nor any other parties be 18 years of age or older, must have a Hong Kong address, involved in the Global Offering is or will be liable for any and must be outside the United States and not a United States information and representations not in the Prospectus (and any Person (as defined in Regulation S under the U.S. Securities supplement to it); Act) and not be a legal or natural person of the PRC. ‧ undertake and confirm that you or the person(s) for whose
• 1. If you are a firm, the application must be in the individual benefit you have made the application have not applied for or members’ names. taken up, or indicated an interest for, and will not apply for
• 1. The number of joint applicants may not exceed 4. or take up, or indicate an interest for, any Offer Shares under 4. If you are a body corporate, the application must be signed the International Offering nor participated in the International by a duly authorised officer, who must state his representative Offering; capacity, and stamped with your corporation’s chop. ‧ agree to disclose to the Company, the Hong Kong Share Registrar,
• 1. Unless permitted by the Listing Rules or any relevant waivers receiving bank, the Joint Sponsors, the Joint Global Coordinators, the Joint Bookrunners, the Joint Lead Managers, the Underwriters

• that have been granted by the Stock Exchange, you cannot and/or their respective advisors and agents any personal data which

• apply for any Hong Kong Offer Shares if you are: ‧ an existing beneficial owner of shares in the Company they may require about you and the person(s) for whose benefit you have made the application;

• ‧ and/or any of its subsidiaries;a Director or chief executive officer of the Company and/ ‧ application, if the laws of any place outside Hong Kong apply to your agree and warrant that you have complied with or any of its subsidiaries;

• ‧ a close associate (as defined under the Listing Rules) of all such laws and none of the Company, the Joint Sponsors, the Joint Global Coordinators, the Joint Bookrunners, the Joint Lead any of the above; Managers, the Underwriters nor any of their respective officers,

• ‧ a core connected person (as defined under the Listing advisors and agents will breach any law outside Hong Kong Rules) of the Company or will become a core connected as a result of the acceptance of your offer to purchase, or any person (as defined under the Listing Rules) of the Company action arising from your rights and obligations under the terms immediately upon completion of the Global Offering; or and conditions contained in the Prospectus and this Application

• ‧ have been allocated or have applied for or indicated Form; an interest in any Offer Shares under the International ‧ agree that once your application has been accepted, you may Offering. not rescind it because of an innocent misrepresentation; ‧ agree that your application will be governed by the laws of

• B. If you are a nominee Hong Kong;

• You, as a nominee, may make more than one application for the ‧ represent , warrant and undertake that (i) you understand Hong Kong Offer Shares by: (i) giving electronic instructions to that the Hong Kong Offer Shares have not been and will not

• HKSCC via Central Clearing and Settlement System (“ CCASS ”) (if be registered under the U.S. Securities Act; and (ii) you and

• you are a CCASS Participant); or (ii) using a WHITE or YELLOW any person for whose benefit you are applying for the Hong

• Application Form, and lodge more than one application in your own Kong Offer Shares are outside the United States (as defined in name on behalf of different beneficial owners. Regulation S) or are a person described in paragraph (h)(3) of C. Effect of completing and submitting this Application Form Rule 902 of Regulation S; By completing and submitting this Application Form, you (and if you ‧ warrant that the information you have provided is true and are joint applicants, each of you jointly and severally) for yourself or accurate; ‧ agree to accept the Hong Kong Offer Shares applied for, or any

• as an agent or a nominee on behalf of each person for whom you act: ‧ undertake to execute all relevant documents and instruct and lesser number allocated to you under the application; ‧ authorise the Company to place your name(s) on the

• authorise the Company and/or the Joint Global Coordinators (or Company’s register of members as the holder(s) of any

• their agents or nominees), as agents of the Company, to execute Hong Kong Offer Shares allocated to you, and the Company

• any documents for you and to do on your behalf all things and/or its agents to send any share certificate(s) and/or any

• necessary to register any Hong Kong Offer Shares allocated to refund cheque(s) to you or the first-named applicant for joint

• you in your name as required by the Articles of Association;

• ‧ agree to comply with the Companies Ordinance (Chapter 622 application by ordinary post at your own risk to the address stated on the application, unless you have fulfilled the criteria

• of the Laws of Hong Kong), the Companies (Winding Up and set out in the section headed “How to Apply for Hong Kong Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws Offer Shares – 14. Despatch/Collection of Share Certificates of Hong Kong) and the Articles of Association; and Refund Monies – Personal Collection” in the Prospectus

• ‧ confirm that you have read the terms and conditions and to collect the share certificate(s) and/or refund cheque(s) in application procedures set out in the Prospectus and in this person;

• ‧ agree to comply with the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong) and the Articles of Association;

• ‧ confirm that you have read the terms and conditions and application procedures set out in the Prospectus and in this Application Form and agree to be bound by them;

• ‧ understand that the Company and the Joint Global Coordinators will rely on your declarations and representations in deciding whether or not to make any allotment of any of the Hong Kong Offer Shares to you and that you may be prosecuted for making a false declaration;

• ‧ confirm that you have received and read the Prospectus and have only relied on the information and representations contained in the Prospectus in making your application and will not rely on any other information or representations except those in any supplement to the Prospectus;

• ‧ declare and represent that this is the only application made and the only application intended by you to be made to benefit you or the person for whose benefit you are applying;

• ‧ confirm that you are aware of the restrictions on the Global Offering in the Prospectus;

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

• ‧ (if the application is made for your own benefit) warrant that no other application has been or will be made for your benefit on a WHITE or YELLOW Application Form or by giving electronic application instructions to HKSCC or to the White Form eIPO Service Provider by you or by any one as your agent or by any other person; and

If you are an individual who is eligible for personal collection, you must not authorise any other person to collect for you. If you are a corporate applicant which is eligible for personal collection, your authorised representative must bear a letter of authorisation from your corporation stamped with your corporation’s chop. Both individuals and authorised representatives must produce, at the time of collection, evidence of identity acceptable to Computershare Hong Kong Investor Services Limited.

‧ (if you are making the application as an agent for the benefit Services Limited. of another person) warrant that (i) no other application has been or will be made by you as agent for or for the benefit of If you do not collect your refund cheque(s) and/or share certificate(s) personally within the time period specified for collection, that person or by that person or by any other person as agent for that person on a WHITE or YELLOW Application Form they will be dispatched promptly to the address as specified on this Application Form by ordinary post at your own risk. or by giving electronic application instructions to HKSCC and (ii) you have due authority to sign the Application Form or If you apply for less than 1,000,000 Hong Kong Offer Shares, give electronic application instructions on behalf of that other your refund cheque(s) and/or share certificate(s) will be sent to the address on the relevant Application Form on or before Monday, person as their agent. November 11, 2019, by ordinary post and at your own risk. D. Power of attorney Refund of your money If your application is made through an authorised attorney, the If you do not receive any Hong Kong Offer Shares or if your Company and the Joint Global Coordinators may accept or reject your application is accepted only in part, the Company will refund to you application at their discretion, and on any conditions they think fit, your application monies (including the related 1% brokerage, 0.0027% including evidence of the attorney’s authority. SFC transaction levy and 0.005% Stock Exchange trading fee) without interest. If the Offer Price is less than the maximum Offer Price, the Determination of Offer Price and Allocation of Hong Kong Offer Company will refund to you the surplus application monies (including Shares the related 1% brokerage, 0.0027% SFC transaction levy and 0.005% The Offer Price is expected to be fixed on or around Tuesday, Stock Exchange trading fee) without interest. November 5, 2019. Applicants are required to pay the maximum The refund procedures are stated in the section headed “How to Apply Offer Price of HK$9.60 for each Hong Kong Offer Share together for Hong Kong Offer Shares – 14. Dispatch/Collection of Share with 1% brokerage, 0.0027% SFC transaction levy and 0.005% Stock Certificates and Refund Monies” in the Prospectus. Exchange trading fee. If the Offer Price is not agreed among the Company and the Joint Global Coordinators (for themselves and on Application by HKSCC Nominees Limited (“HKSCC Nominees”) Where this Application Form is signed by HKSCC Nominees on behalf of the Underwriters) on or before Wednesday, November 6, behalf of persons who have given electronic application instructions 2019, the Global Offering will not proceed. to apply for the Hong Kong Offer Shares, the provisions of this Applications for Hong Kong Offer Shares will not be processed and Application Form which are inconsistent with those set out in the no allotment of any Hong Kong Offer Shares will be made until the Prospectus shall not apply and provisions in the Prospectus shall application lists close. prevail. Without limiting the generality of this paragraph, the following The Company expects to announce the final Offer Price, the indication sections of this Application Form are inapplicable where this form is of the level of interest in the International Offering, the level of signed by HKSCC Nominees: applications under the Hong Kong Public Offering and the basis of ‧ “Applicants’ declaration” on the first page; allocation of the Hong Kong Offer Shares on Monday, November 11, ‧ “Warning” on the first page; 2019 on the website of the Stock Exchange at www.hkexnews.hk and ‧ “If you are a nominee”; the Company’s website at www.sinomab.com . Results of allocations ‧ All representations and warranties under the “Effect of and the Hong Kong Identity Card/passport/Hong Kong business completing and submitting this Application Form” section, registration numbers of successful applicants (where applicable) will except the first one regarding registration of Hong Kong Offer be available on the above websites. Shares in the applicant’s name and the signing of documents to enable the applicant to be registered as the holder of the Hong The allocation of Offer Shares between the Hong Kong Public Kong Offer Shares; Offering and the International Offering is subject to adjustment as ‧ “If your application for Hong Kong Offer Shares is successful detailed in the section headed “Structure of the Global Offering – (in whole or in part)”; and The Hong Kong Public Offering – Reallocation” in the Prospectus. In ‧ “Refund of your money”. particular, the Joint Global Coordinators may reallocate Offer Shares The following sections in the section headed “How to Apply for Hong from the International Offering to the Hong Kong Public Offering Kong Offer Shares” in the Prospectus are inapplicable where this form to satisfy valid applications under the Hong Kong Public Offering. is signed by HKSCC Nominees: In accordance with Guidance Letter HKEX-GL91-18 issued by the ‧ “8. How many applications can you make”; and Stock Exchange, if such reallocation is done other than pursuant to ‧ “12. Circumstances in which You Will Not be Allotted Hong Practice Note 18 of the Listing Rules, the maximum total number Kong Offer Shares”. of Offer Shares under the Hong Kong Public Offering following Effect of the Information You Give Us such reallocation shall be not more than 36,426,000 Offer Shares, Computershare Hong Kong Investor Services Limited and its representing double of the initial allocation to the Hong Kong Public related bodies’ corporate, directors, officers, employees and Offering, and the final Offer Price shall be fixed at the low-end of the agents (“ Representatives ”) expressly disclaim and exclude to indicative offer price range (i.e. HK$7.60 per Offer Share). the maximum extent permitted by law any liability for any loss

Computershare Hong Kong Investor Services Limited and its related bodies’ corporate, directors, officers, employees and agents (“ Representatives ”) expressly disclaim and exclude to the maximum extent permitted by law any liability for any loss or damage suffered or incurred by the applicant or any other person or entity however caused relating in any way to, or connected with, any information provided by or on behalf of the applicant on or in connection with this document or any services provided hereunder, or any other written or oral communication provided by or on behalf of the applicant in connection with this document or any services provided hereunder. This includes, without limitation, any errors or omissions in such information however caused, or the Representatives or any other person or entity placing any reliance on such information or any documentation, image, recording or reproduction of such information, or its accuracy, completeness, currency or reliability.

If your application for Hong Kong Offer Shares is successful (in whole or in part)

If you apply for 1,000,000 or more Hong Kong Offer Shares, you may collect refund cheque(s) and/or share certificate(s) in person from Computershare Hong Kong Investor Services Limited, Shops 17121716, 17th Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong, from 9:00 a.m. to 1:00 p.m. on Monday, November 11, 2019 or such other date as notified by us on the website of the Stock Exchange at www.hkexnews.hk and the Company’s website at www.sinomab.com .

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

==> picture [29 x 43] intentionally omitted <==

==> picture [29 x 43] intentionally omitted <==

SinoMab BioScience Limited 中國抗體製藥有限公司 （於香港註冊成立的有限公司）

全球發售

• 申請條件 ‧ 確認 閣下知悉招股章程內有關全球發售的限制； ‧ 同意 本公司、聯席保薦人、聯席全球協調人、聯席

• 甲、 可提出申請的人士 賬簿管理人、聯席牽頭經辦人、包銷商及彼等各自 1. 閣下及 閣下為其利益提出申請的人士必須年滿 18 的董事、高級職員、僱員、合夥人、代理、顧問及 歲並有香港地址，身處美國境外且並非美籍人士 參與全球發售的任何其他各方現時及日後均毋須對

• （定義見美國證券法 S 規例）及並非中國法人或自然 並非載於招股章程（及其任何補充文件）的任何資料 人。 及陳述負責；

• 1. 如 閣下為商號，申請須以個別成員名義提出。 ‧ 承諾 及 確認 閣下或 閣下為其利益提出申請的人 3. 聯名申請人不得超過四名。 士並無申請或接納或表示有意認購（亦不會申請或
• 1. 如 閣下為法人團體，申請須經獲正式授權人員簽 接納或表示有意認購）國際發售的任何發售股份，

• 署，並註明其所屬代表身份及蓋上公司印鑑。 也沒有參與國際發售；

• 1. 除上市規則或聯交所已授予的任何相關豁免外，下 ‧ 同意 向本公司、香港證券登記處、收款銀行、聯席

• 列人士概不得申請認購任何香港發售股份： ‧ 保薦人、聯席全球協調人、聯席賬簿管理人、聯席 本公司及╱或其任何附屬公司股份的現有實益 牽頭經辦人、包銷商及╱或彼等各自的顧問及代理

• 擁有人；

• ‧ 披露其所要求有關 閣下及 閣下為其利益提出申 本公司及╱或其任何附屬公司的董事或行政總 請的人士的個人資料；

• 裁； ‧

• ‧ 若香港境外任何地方的法例適用於 閣下的申請， 上述任何人士的緊密聯繫人（定義見上市規 則 同意 及 保證 閣下已遵守所有有關法例，且本公

• 則）；

• ‧ 本公司核心關連人士（定義見上市規則）或緊 司、聯席保薦人、聯席全球協調人、聯席賬簿管理 隨全球發售完成後將成為本公司核心關連人士 人、聯席牽頭經辦人、包銷商及彼等各自的高級職

• （定義見上市規則）的人士；或 員、顧問及代理概不會因接納 閣下的購買要約，

• ‧ 已獲分配或已申請或表示有意申請國際發售的 或 閣下在招股章程及本申請表格所載的條款及條 任何發售股份。 件項下的權利及責任所引致的任何行動，而違反香 港境外的任何法例；

• 乙、 如 閣下為代名人 ‧ 同意 閣下的申請一經接納，即不得因無意的失實 閣下作為代名人可提交超過一份香港發售股份申請，方 陳述而撤銷； 法是：(i) 透過中央結算及交收系統（「 中央結算系統 」）向 ‧ 同意 閣下的申請受香港法例規管； 香港結算發出電子認購指示（如 閣下為中央結算系統 ‧ 表示 、 保證 及 承諾 (i) 閣下明白香港發售股份並 參與者）；或 (ii) 使用 白色 或 黃色 申請表格，以自身名義 無及將不會根據美國證券法登記；及 (ii) 閣下 代表不同的實益擁有人提交超過一份申請。 及 閣下為其利益提出申請香港發售股份的任何 人士身處美國境外（定義見 S 規例），或屬 S 規例第

• 丙、 填交本申請表格的效用 902 條第 (h)(3) 段所述的人士；

• 閣下填妥並遞交本申請表格，即表示 閣下（如屬聯名 ‧ 保證 閣下提供的資料真實及準確； 申請人，即各人共同及個別）代表 閣下本身，或作 ‧ 同意 接納所申請數目或根據申請分配予 閣下但數

• 為 閣下代其行事的每位人士的代理或代名人： 目較少的香港發售股份；

• ‧ 承諾 簽立所有相關文件，並指示及授權本公司及╱ ‧ 授權 本公司將 閣下的姓名╱名稱列入本公司股東

• 或聯席全球協調人（或彼等的代理或代名人）（作為 名冊，作為 閣下獲分配的任何香港發售股份的持

• 本公司代理）為 閣下簽立任何文件及代表 閣下 有人，並授權本公司及╱或其代理以普通郵遞方式

• 辦理一切必要事宜，以按照章程細則的規定將 閣 按申請所示地址向 閣下或聯名申請的首名申請人

• 下獲分配的任何香港發售股份以 閣下名義登記；

• ‧ 授權 本公司將 閣下的姓名╱名稱列入本公司股東 名冊，作為 閣下獲分配的任何香港發售股份的持 有人，並授權本公司及╱或其代理以普通郵遞方式 按申請所示地址向 閣下或聯名申請的首名申請人 發送任何股票及╱或退款支票，郵誤風險由 閣下 承擔，除非 閣下已符合招股章程「如何申請香港 發售股份－14. 發送╱領取股票及退回股款－親身 領取」一節的條件親身領取股票及╱或退款支票；

• ‧ 同意 遵守香港法例第 622 章公司條例、香港法例第 32 章公司（清盤及雜項條文）條例及章程細則；

• ‧ 確認 閣下已細閱招股章程及本申請表格所載的條 款及條件以及申請程序，並同意受其約束；

• ‧ 明白 本公司及聯席全球協調人將依據 閣下的聲明 及陳述而決定是否向 閣下分配任何香港發售股 份， 閣下如作出虛假聲明，可能會被檢控；

• ‧ 確認 閣下已接獲及細閱招股章程，提出申請時也 僅依據招股章程載列的資料及陳述，而除招股章程 任何補充文件外，不會依賴任何其他資料或陳述；

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

如 閣下為個人申請人並合資格親身領取， 閣下不得 授權任何其他人士代領。如 閣下為公司申請人並合資 格親身領取， 閣下的授權代表須攜同蓋上公司印鑑的 授權書領取。個人申請人及授權代表領取股票時均須出 示香港中央證券登記有限公司接納的身份證明文件。

• ‧ 聲明 及 陳述 此乃 閣下為本身或為其利益提出申請 的人士所提出及擬提出的唯一申請；

• ‧ （如本申請為 閣下本身的利益提出） 保證 閣下或 作為 閣下代理的任何人士或任何其他人士不曾亦 不會為 閣下的利益以 白色 或 黃色 申請表格或向香 港結算或向 白表 eIPO 服務供應商發出 電子認購指 示 而提出其他申請；及

如 閣下並無在指定領取時間內親身領取退款支票及╱ 或股票，有關股票將會立刻以普通郵遞方式寄往本申請 表格所示地址，郵誤風險由 閣下承擔。

‧ （如 閣下作為代理為另一人士的利益提出申請） 保 證 (i) 閣下（作為代理或為該人士利益）或該人士或 如 閣下申請認購 1,000,000 股以下香港發售股份， 閣 下的退款支票及╱或股票將於二零一九年十一月十一日 任何其他作為該人士代理的人士不曾亦不會以 白色 （星期一）或以前以普通郵遞方式寄往相關申請表格所示 或 黃色 申請表格或向香港結算發出 電子認購指示 而 地址，郵誤風險由 閣下承擔。 提出其他申請；及 (ii) 閣下獲正式授權作為該人士 。 退回款項 的代理代為簽署本申請表格或發出 電子認購指示 若 閣下未獲分配任何香港發售股份或申請僅部分獲接 丁、 授權書 納，本公司將不計利息退回 閣下的申請股款（包括相 如 閣下透過授權人士提出申請，本公司及聯席全球協 關的 1% 經紀佣金、0.0027% 證監會交易徵費及 0.005% 調人可按其認為合適的條件（包括出示獲授權證明）酌情 聯交所交易費）。如發售價低於最高發售價，本公司將 接納或拒絕 閣下的申請。 不計利息退回多收申請股款（包括相關的 1% 經紀佣金、 0.0027% 證監會交易徵費及 0.005% 聯交所交易費）。 釐定發售價及香港發售股份的分配 有關退款程序載於招股章程「如何申請香港發售股份－ 預期發售價於二零一九年十一月五日（星期二）或前後釐 14. 發送╱領取股票及退回股款」一節。 定。申請人須繳付每股香港發售股份 9.60 港元的最高發 香港中央結算（代理人）有限公司（「香港結算代理人」）提 售價，另加 1% 經紀佣金、0.0027% 證監會交易徵費及 出的申請 0.005% 聯交所交易費。倘若本公司與聯席全球協調人 如本申請表格由香港結算代理人代表發出 電子認購指示 （為其自身及代表包銷商）並無於二零一九年十一月六日 申請香港發售股份的人士簽署，本申請表格與招股章程 （星期三）或之前協定發售價，全球發售將不會進行。 不符的條文將不適用，且以招股章程所述者為準。 截止登記認購申請前，概不處理香港發售股份的申請或 在不限制此段一般應用的前提下，本申請表格的以下部 配發任何香港發售股份。 分在香港結算代理人作簽署人的情況下並不適用： ‧ 第一頁的「申請人聲明」； 本公司預期於二零一九年十一月十一日（星期一） ‧ 第一頁的「警告」； 在聯交所網站 ( www.hkexnews.hk ) 及本公司網站 ‧ 「如 閣下為代名人」； ( www.sinomab.com ) 公佈最終發售價、國際發售踴躍程 ‧ 「填交本申請表格的效用」一節項下的所有陳述及保 度、香港公開發售認購申請水平及香港發售股份分配基 證，惟首項有關以申請人名義登記香港發售股份及 準。分配結果以及獲接納申請人的香港身份證╱護照╱ 簽署使申請人登記成為香港發售股份持有人的文件 香港商業登記號碼（如適用）亦同於上述網站公佈。 除外； ‧ 「如 閣下成功申請認購香港發售股份（全部或部 發售股份在香港公開發售與國際發售之間的分配可如招 分）」；及 股章程「全球發售的架構－香港公開發售－重新分配」一 ‧ 「退回款項」。 節所述調整。特別是，聯席全球協調人可將發售股份由 招股章程「如何申請香港發售股份」一節的以下部分在香 國際發售重新分配至香港公開發售，以滿足香港公開發 港結算代理人作簽署人的情況下並不適用： 售項下的有效申請。根據聯交所發表的指引信 HKEX‧ 「8. 閣下可提交的申請數目」；及 GL91-18，倘有關重新分配並非根據上市規則第 18 項應 ‧ 「12. 閣下將不獲配發香港發售股份的情況」。 用指引完成，有關重新分配後，香港公開發售的發售股 您提供給我們的資訊的有關影響 份總數最多將不超過 36,426,000 股發售股份，相當於初 香港中央證券登記有限公司和其有關連的法人團體、董 步分配至香港公開發售股份數目的兩倍，而最終發售價 事、高級人員、僱員及代理人（「 代表 」）在法律所容許的 將為指示性發售價範圍的下限（即每股發售股份 7.60 港 最大限度內明確卸棄及免除在任何方面與申請人或代表 元）。 申請人在此文件提供的或與此文件或在此文件下提供的 任何服務相關的任何資料，或任何申請人或代表申請人 如 閣下成功申請認購香港發售股份（全部或部分） 提供與此文件或在此文件下提供的任何服務相關的任何 如 閣下申請認購 1,000,000 股或以上香港發售股 股或以上香港發售股 其它書面或口頭通訊，有關或相關由申請人或任何其他 份， 閣下可於二零一九年十一月十一日（星期一）或 人士或實體所遭受或招致不論如何造成的任何損失或損 吾等在聯交所網站 ( www.hkexnews.hk ) 及本公司網站 及本公司網站 害的任何法律責任。此包括，但不限於，該等資料中不 ( www.sinomab.com ) 的其他日期上午九時正至下午一時 的其他日期上午九時正至下午一時 論如何造成的任何錯誤或遺漏，或代表或任何其他人士 正自香港中央證券登記有限公司（地址為香港灣仔皇后 或實體對該等資料或任何該等資料的文件記錄、影像、 大道東 183 號合和中心 號合和中心 17 樓 樓 1712－1716 室）領取退款支－1716 室）領取退款支1716 室）領取退款支 室）領取退款支 記錄或複製品作出的任何依據，或其準確性、完整性、 票及╱或股票。 合時性或可靠性。

如 閣下申請認購 1,000,000 股或以上香港發售股 股或以上香港發售股 份， 閣下可於二零一九年十一月十一日（星期一）或 吾等在聯交所網站 ( www.hkexnews.hk ) 及本公司網站 及本公司網站 ( www.sinomab.com ) 的其他日期上午九時正至下午一時 的其他日期上午九時正至下午一時 正自香港中央證券登記有限公司（地址為香港灣仔皇后 大道東 183 號合和中心 號合和中心 17 樓 樓 1712－1716 室）領取退款支－1716 室）領取退款支1716 室）領取退款支 室）領取退款支 票及╱或股票。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

• ‧ any other incidental or associated purposes relating to the above and/or to enable the Company and the Hong Kong Share Registrar to discharge their obligations to securities’ holders and/or regulators and/or any other purposes to which the securities’ holders may from time to time agree.

Personal Data

Personal Information Collection Statement

This Personal Information Collection Statement informs the applicant for, and holder of, Hong Kong Offer Shares, of the policies and practices of the Company and its Hong Kong Share Registrar in relation to personal data and the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong) (the “ Ordinance ”).

3. Transfer of personal data

Personal data held by the Company and its Hong Kong Laws of Hong Kong) (the “ Ordinance ”). Share Registrar relating to the securities holders will be 1. Reasons for the collection of your personal data kept confidential but the Company and its Hong Kong It is necessary for applicants and registered holders of Share Registrar may, to the extent necessary for achieving securities to supply correct personal data to the Company any of the above purposes, disclose, obtain or transfer or its agents and the Hong Kong Share Registrar when (whether within or outside Hong Kong) the personal data applying for securities or transferring securities into or out to, from or with any of the following: ‧ the Company’s appointed agents such as financial of their names or in procuring the services of the Hong advisers, receiving bankers and overseas principal Kong Share Registrar. share registrar; ‧ Failure to supply the requested data may result in your where applicants for securities request a deposit into application for securities being rejected, or in delay or CCASS, HKSCC or HKSCC Nominees, who will the inability of the Company or its Hong Kong Share use the personal data for the purposes of operating Registrar to effect transfers or otherwise render their CCASS; services. It may also prevent or delay registration or ‧ any agents, contractors or third-party service providers transfers of the Hong Kong Offer Shares which you have who offer administrative, telecommunications, successfully applied for and/or the dispatch of share computer, payment or other services to the Company or the Hong Kong Share Registrar in connection with certificate(s) and/or refund cheque(s) to which you are entitled. their respective business operation; ‧ the Stock Exchange, the SFC and any other statutory It is important that securities holders inform the Company regulatory or governmental bodies or otherwise as and the Hong Kong Share Registrar immediately of any required by laws, rules or regulations; and inaccuracies in the personal data supplied. ‧ any persons or institutions with which the securities’ holders have or propose to have dealings, such as 2. Purposes their bankers, solicitors, accountants or stockbrokers The personal data of the securities holders may be used, etc. held, processed, and/or stored (by whatever means) for 4. Retention of personal data the following purposes: ‧ The Company and its Hong Kong Share Registrar will processing your application and refund cheque, keep the personal data of the applicants and holders of where applicable, verification of compliance with securities for as long as necessary to fulfil the purposes the terms and application procedures set out in for which the personal data were collected. Personal data this Application Form and the Prospectus and which is no longer required will be destroyed or dealt announcing results of allocation of the Hong Kong with in accordance with the Ordinance. Offer Shares; ‧ compliance with applicable laws and regulations in 5. Access to and correction of personal data Securities holders have the right to ascertain whether Hong Kong and elsewhere; ‧ the Company or the Hong Kong Share Registrar hold registering new issues or transfers into or out of their personal data, to obtain a copy of that data, and to the names of securities’ holders including, where correct any data that is inaccurate. The Company and the applicable, HKSCC Nominees; ‧ maintaining or updating the register of securities’ Hong Kong Share Registrar have the right to charge a reasonable fee for the processing of such requests. holders of the Company;

5. Access to and correction of personal data Securities holders have the right to ascertain whether the Company or the Hong Kong Share Registrar hold their personal data, to obtain a copy of that data, and to correct any data that is inaccurate. The Company and the Hong Kong Share Registrar have the right to charge a reasonable fee for the processing of such requests.

All requests for access to data or correction of data should be addressed to us, at our registered address disclosed in the section headed “Corporate Information” in the Prospectus or as notified from time to time, for the attention of the company secretaries, or our Hong Kong Share Registrar for the attention of the privacy compliance officer.

• ‧ verifying securities holders’ identities;

• ‧ establishing benefit entitlements of securities’ holders of the Company, such as dividends, rights issues, bonus issues, etc.;

• ‧ distributing communications from the Company and its subsidiaries;

• ‧ compiling statistical information and securities’ holder profiles;

By signing an Application Form or by giving electronic application instructions to HKSCC, you agree to all of the above.

• ‧ disclosing relevant information to facilitate claims on entitlements; and

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

3. 轉交個人資料 本公司及其香港證券登記處所持有關證券持有人 的個人資料將會保密，但本公司及其香港證券登 記處可以在為達到上述任何目的之必要情況下， 向下列任何人士披露，獲取或轉交（無論在香港 境內或境外）有關個人資料：

個人資料

個人資料收集聲明

此項個人資料收集聲明是向香港發售股份的申請 記處可以在為達到上述任何目的之必要情況下， 人和持有人說明有關本公司及其香港證券登記處 向下列任何人士披露，獲取或轉交（無論在香港 有關個人資料和香港法例第 486 章《個人資料（私 境內或境外）有關個人資料： 隱）條例》（「 條例 」）方面的政策和措施。 ‧ 本公司委任的代理人，例如財務顧問、收款 銀行和海外主要股份過戶登記分處； 1. 收集 閣下個人資料的原因 ‧ 如證券申請人要求將證券存於中央結算系 證券申請人及登記持有人以本身名義申請證券或 統、香港結算或香港結算代理人；彼等將會 轉讓或受讓證券時或尋求香港證券登記處的服務 就中央結算系統的運作使用有關個人資料； ‧ 時，必須向本公司或其代理人及香港證券登記處 向本公司或香港證券登記處提供與其各自業 提供準確個人資料。 務營運有關的行政、電訊、電腦、付款或其 他服務的任何代理人、承包商或第三方服務 未能提供所要求的資料可能導致 閣下申請證券 供應商； 被拒或延遲，或本公司或其香港證券登記處無法 ‧ 聯交所、證監會及任何其他法定監管機關或 落實轉讓或提供服務。此舉也可能妨礙或延遲登 政府部門或其他法例、規則或法規另行規定 記或轉讓 閣下成功申請的香港發售股份及╱或 者；及 ‧ 寄發 閣下應得的股票及╱或退款支票。 證券持有人與其進行或擬進行交易的任何人 士或機構，例如彼等的銀行、律師、會計師 證券持有人所提供的個人資料如有任何錯誤，須 或股票經紀等。 立即通知本公司及香港證券登記處。 4. 個人資料的保留 2. 目的 本公司及其香港證券登記處將按收集個人資料所 證券持有人的個人資料可被採用及以任何方式持 需的用途保留證券申請人及持有人的個人資料。 有、處理及╱或保存，以作下列用途： 無需保留的個人資料將會根據條例銷毀或處理。 ‧ 處理 閣下的申請及退款支票（如適用）、核 實是否符合本申請表格及招股章程載列的條 5. 查閱和更正個人資料 款和申請程序以及公佈香港發售股份的分配 證券持有人有權確定本公司或香港證券登記處是 結果； 否持有其個人資料，並有權索取有關該資料的副 ‧ 遵守香港及其他地區的適用法律及法規； 本並更正任何不準確資料。本公司和香港證券登 ‧ 記處有權就處理任何查閱資料的要求收取合理費 以證券持有人（包括香港結算代理人（如適 用。 用））的名義登記新發行證券或轉讓或受讓證 券； 所有查閱資料或更正資料的要求應按招股章程 ‧ 存置或更新本公司證券持有人的名冊； 「公司資料」一節所披露或不時通知的本公司註冊 ‧ 核實證券持有人的身份； 地址送交公司秘書，或向本公司的香港證券登記 ‧ 確定本公司證券持有人的受益權利，例如股 處的私隱事務主任提出。 息、供股和紅股等；

閣下簽署申請表格或向香港結算發出電子認購指 示，即表示同意上述各項。

• ‧ 分發本公司及其附屬公司的通訊；

• ‧ 編製統計數據和證券持有人資料；

• ‧ 披露有關資料以便就權益索償；及

• ‧ 與上述有關的任何其他附帶或相關目的及╱ 或使本公司及香港證券登記處能履行對證券 持有人及╱或監管機構承擔的責任及╱或證 券持有人不時同意的任何其他目的。